Photo-activated riboflavin therapy of refractory corneal ulcers

Cornea. 2012 Oct;31(10):1210-3. doi: 10.1097/ICO.0b013e31823f8f48.

Abstract

Purpose: To evaluate the therapeutic effect of photo-activated riboflavin (PAR) for treating refractory corneal ulcers.

Methods: Seven eyes with infectious keratitis, presented with a gradually deteriorating, vision-threatening, corneal ulcer, despite intense antimicrobial therapy, were treated with PAR. The surgical procedure was deepithelialization of the affected corneas followed by UV-A riboflavin (B2) cross-linking. Local antimicrobial therapy was continued after the procedure.

Results: In all cases, the progression of corneal melting was halted after PAR treatment. Emergency keratoplasty was not necessary in any of the 7 eyes presented. More importantly, all the ulcers were healed without significant vascularization.

Conclusion: PAR is a promising option for treating patients with therapy-refractory infectious keratitis to avoid emergency keratoplasty and should be considered as a potential adjuvant therapeutic tool in such eyes.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-Infective Agents / therapeutic use
  • Corneal Ulcer / drug therapy*
  • Corneal Ulcer / microbiology
  • Corneal Ulcer / parasitology
  • Eye Infections / drug therapy*
  • Eye Infections / microbiology
  • Eye Infections / parasitology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Photochemotherapy*
  • Photosensitizing Agents / therapeutic use*
  • Riboflavin / therapeutic use*
  • Treatment Outcome
  • Ultraviolet Rays
  • Visual Acuity / physiology

Substances

  • Anti-Infective Agents
  • Photosensitizing Agents
  • Riboflavin